Skip to main content

Day: April 3, 2024

Reliance Global Group Schedules Fourth Quarter 2023 Financial Results and Business Update Conference Call

Lakewood, NJ, April 03, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (NASDAQ: RELI; RELIW) (“Reliance” or the “Company”), announced today that it will host a conference call Thursday, April 4, 2024, at 1:00 PM Eastern Time to discuss financial results for the fourth quarter of 2023 and provide a business update. The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 515451. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2381/50129 or on the investor relations section of the company’s website, https://relianceglobalgroup.com/events-and-presentations/. A webcast replay will be available on the investor relations section of the company’s website at https://relianceglobalgroup.com/events-and-presentations/...

Continue reading

Falco Announces Granting of Stock Options

MONTREAL, April 03, 2024 (GLOBE NEWSWIRE) — Falco Resources Ltd. (TSX.V: FPC) (“Falco” or the “Corporation”) announces that the Board of Directors approved the grant of incentive stock options to key employees, officers and directors to purchase up to an aggregate of 3,440,000 common shares in the capital stock of the Corporation. Grants are subject to a three-year vesting period and a five-year term. The options were granted at an exercise price of $0.36 per share being the closing price of the common shares of the Corporation on the TSX Venture Exchange on April 2, 2024. About Falco Falco Resources Ltd. is one of the largest mineral claim holders in the Province of Québec, with extensive land holdings in the Abitibi Greenstone Belt. Falco owns approximately 67,000 hectares of land in the Noranda Mining Camp, which represents...

Continue reading

TeraWulf Releases Inaugural Corporate Social Responsibility Report

Highlights the Company’s Industry Leading ESG and Sustainability Efforts EASTON, Md., April 03, 2024 (GLOBE NEWSWIRE) — TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), owners and operators of vertically integrated, domestic bitcoin mining facilities powered by 95% zero-carbon energy, today released its inaugural Corporate Social Responsibility (CSR) report for fiscal year 2023. This comprehensive report outlines TeraWulf’s commitments, goals, and initiatives across various CSR and environmental, social, and governance (ESG) issues.  Since its public launch in 2021, TeraWulf has been steadfastly building a robust ESG foundation to support its growth and mission of supporting the energy transition through sustainable bitcoin mining practices. Kerri Langlais, Chief Strategy Officer at TeraWulf, commented, “With the release...

Continue reading

Independent Publisher Implements Bridgeline’s HawkSearch

WOBURN, Mass., April 03, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing technology software, announced today that a large independent publishing house has implemented HawkSearch on five of its eCommerce sites. HawkSearch will bolster the publisher’s growth strategy through AI-powered search within the publisher’s catalog of over twenty-thousand products across five websites. HawkSearch will make the online catalog easier to navigate through site search, autocomplete, and recommendations. For example, a user can search for “Texas Football Autobiography,” and HawkSearch will display the title “Game On,” by the Dallas Cowboys’ legend Emmitt Smith. The publisher will use HawkSearch Recommendations to power personalized shopping experiences that increase the average size of each order. HawkSearch...

Continue reading

Matinas BioPharma Prices $10 Million Registered Direct Offering

BEDMINSTER, N.J., April 03, 2024 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) (“Matinas BioPharma” or the “Company”), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, today announced it has entered into securities purchase agreements with healthcare-focused institutional investors for the purchase and sale of 33,333,334 shares of common stock, par value $0.0001 per share, and warrants to purchase up to an aggregate of 33,333,334 shares of common stock, at a combined offering price of $0.30 per share and accompanying warrant, pursuant to a registered direct offering. The warrants will have an exercise price of $0.35 per share, will be exercisable commencing six months from the date of issuance and...

Continue reading

LiveOne (Nasdaq: LVO) Announces $11.3M Series A Preferred Stock Conversion to Common Stock at $2.10 per Share, Led by Harvest Small Cap Partners Master, Ltd. and Trinad Capital Master Fund

– Conversion Eliminates $2.0M of Annual Cash Dividends – Eliminates $5M of Redeemable Mezzanine Equity – Broadens Institutional Ownership to ~35% – LiveOne Currently Eligible to Join Russell 2000 in May 2024 – LiveOne Acquired Additional 159,000 PODC Shares at a Price of $3 per Share During March 2024 LOS ANGELES, CA, April 03, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Robert Ellin, the CEO and Chairman of LiveOne, stated, “Jeff Osher, the Managing Member of the Harvest Funds, has successfully invested and partnered in many of my companies for over 20 years. He is renowned as one of the best small cap investors around the globe. I’m honored and excited that Jeff has once again shown extraordinary confidence in choosing to convert his interest-bearing perpetual preferred stock into our common...

Continue reading

Micron Provides Update Following Earthquake in Taiwan

BOISE, Idaho, April 03, 2024 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) today reported that following the earthquake that struck Taiwan on April 3, 2024, all of Micron’s team members have been accounted for and reported to be safe. Our thoughts are with those affected and their families. We are evaluating impact to our operations and supply chain. We will communicate changes to delivery commitments to our customers after this evaluation is completed. About Micron Technology, Inc. We are an industry leader in innovative memory and storage solutions transforming how the world uses information to enrich life for all. With a relentless focus on our customers, technology leadership, and manufacturing and operational excellence, Micron delivers a rich portfolio of high-performance DRAM, NAND and NOR memory and storage products...

Continue reading

Vemanti Gains Hospitality Digital Transformation Capabilities Across SE Asia with Acquisition of VinHMS

IRVINE, Calif., April 03, 2024 (GLOBE NEWSWIRE) — Vemanti Group, Inc. (“Vemanti” or the “Company”) (OTCQB: VMNT) today announced the successful acquisition of VinHMS Pte. Ltd. (“VinHMS”), a Singapore-based technology solutions provider specializing in digital transformation for the hospitality industry across Southeast Asia. This transaction marks a strategic achievement for Vemanti, placing the Company at the forefront of the hospitality technology sector and reinforcing its commitment to becoming a leader in digital innovation. The business combination brings together complementary strengths for both organizations, with the opportunity to bolster operational capabilities, expand market reach, and drive revenue growth. With operations in Vietnam, Singapore, Cambodia, Thailand, and upcoming expansion plans for Indonesia and the...

Continue reading

BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia

ANAHEIM, CA, April 03, 2024 (GLOBE NEWSWIRE) — via NewMediaWire —  BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer of innovative treatment programs for substance use and related disorders, today announced that its subsidiary BioCorRx Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, has been granted a new patent by the United States Patent and Trademark Office (USPTO). The USPTO has issued U.S. Patent No. 11,793,801 entitled, “Treatment of Pain and Neurological Conditions”. The patent is directed towards the use of a compound and composition and/or dosage form for treating pain, depression, and schizophrenia.  Lourdes Felix, CEO, CFO, and Director of BioCorRx Inc., and President, and Chairman of BioCorRx Pharmaceuticals Inc., commented, “The patented invention may offer a novel approach to reducing...

Continue reading

ContextLogic Reminds Stockholders to Vote FOR the Value-Maximizing Transaction with Qoo10 Today

 Proposed Transaction Ensures Preservation of $2.7 billion in NOLsOutlines Support for Transaction from ContextLogic Investors and Proxy Advisory FirmsSpecial Meeting of Stockholders is Friday, April 12, 2024, at 10:00 A.M. Pacific Time SAN FRANCISCO, April 03, 2024 (GLOBE NEWSWIRE) — ContextLogic Inc. (d/b/a Wish) (NASDAQ: WISH) (“ContextLogic” or the “Company”) today issued a reminder to stockholders to vote “FOR” the proposed Asset Sale transaction with Qoo10 Pte. Ltd. (“Qoo10”) in connection with the upcoming special meeting of stockholders (the “Special Meeting”) on April 12, 2024, at 10:00 a.m. Pacific Time. The ContextLogic Board of Directors reiterates its belief that the proposed transaction will reduce substantially all of the cash burn, monetize operating assets at the highest value available and preserve significant...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.